Clinical Trial Update: Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing metyrapone with osilodrostat in patients with Mild Autonomous Cortisol Secretion (MACS) is currently recruiting in Athens, Gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomous Cortisol Secretion

Drugs mentioned

• Metyrapone (Metyrapone)
• Osilodrostat (osilodrostat)

Snippet

Sponsor: Laikο General Hospital, Athens | Conditions: Mild Autonomous Cortisol Secretion (MACS) | Phase 4 | Status: RECRUITING